Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Lipid Metabolism Disorders » Dyslipidemias » Hyperlipidemias » Hypercholesterolemia
Description
A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. MeSH
Hierarchy View
Approved Indicated Drugs (27)
Phase 4 Indicated Drugs (34)
Phase 3 Indicated Drugs (55)
Phase 2 Indicated Drugs (36)
Phase 1 Indicated Drugs (33)
Other Experimental Indicated Drugs (59)
Organization Involved with Phase 4 Indications (105)
American Society of Health-System Pharmacists Research and Education Foundation
Atlanta Research and Education Foundation
Bio-Inova Life Sciences International
Birjand University of Medical Sciences
Hellenic Atherosclerosis Society
Institute for Health Research IdiPAZ
Instituto Aragones de Ciencias de la Salud
Kuhnil Pharmaceutical Co., Ltd.
Le Point Medical - Rond Point du Jour
Nicolaus Copernicus University
Pontificia Universidad Catolica de Chile
State University of New York, Buffalo
Tuscaloosa Research & Education Advancement Corporation (TREAC)
Universidad Autonoma de Madrid
Organization Involved with Phase 3 Indications (76)
Ache Laboratorios Farmaceuticos S.A.
Centers for Disease Control and Prevention (CDC)
Centre d'Atenció Primaria Bon Pastor
Centro de Atención Primaria Alcover, Tarragona (Spain)
Chinese Academy of Medical Sciences
Daewon Pharmaceutical Co., Ltd.
Heartbeats Life Centre, New Orleans, USA
Hospital General Universitario Gregorio Marañon
Hospital Saint Franciscus Gasthuis, Rotterdam
Innovent Biologics (Suzhou) Co. Ltd.
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Aging (NIA)
National Institutes of Health (NIH)
Office of Dietary Supplements (ODS)
Taichung Veterans General Hospital
Organization Involved with Phase 2 Indications (85)
AD Pharmaceuticals Co., Ltd. (Guangzhou)
Agriculture and Agri-Food Canada
Agri-Food Research and Development Initiative
Alberta Innovates Health Solutions
Aristotle University of Thessaloniki
Doris Duke Charitable Foundation
Federal University of Rio Grande do Sul
Glycemic Index Laboratories, Inc
Jacksonville Center for Clinical Research
Medical Research Laboratories International
Organization Involved with Phase 1 Indications (20)
Organization Involved with Other Experimental Indications (79)
Analysis and Research Network, S.L
Beijing Research Institute for Nutrition Resources
Biomedical Foundation for Cardiovascular Research of Padova
Canadian Institutes of Health Research (CIHR)
Castilla-La Mancha Health Research Foundation.
Clinical Research Institute HUCH Ltd
Commonwealth Scientific and Industrial Research Organisation, Australia
Fondazione Edmund Mach di San Michele all'Adige
Fundación para la Investigación Sanitaria en Castilla-La Mancha (FISCAM)
Gerencia de Atención Primaria, Albacete
Inner Mongolia Yili Industrial Group Co., Ltd
Integrative Health Technologies
National Center for Research Resources (NCRR)
National Health and Medical Research Council, Australia
National Institute of Allergy and Infectious Diseases (NIAID)
People's Liberation Army of China
Pin Siang Medical Biotechnology Co., Ltd.
The Beverage Institute for Health and Wellness
United States Department of Agriculture
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.